REG - Biome Technologies - Trading Update

Biome TechnologiesAnnouncement

06/02/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240206:nRSF0845Ca&default-theme=true

RNS Number : 0845C  Biome Technologies PLC  06 February 2024

The information contained within this announcement is deemed by the Company to
constitute inside information for the purposes of Regulation 11 of the Market
Abuse (Amendment) (EU Exit) Regulations 2019/310.

 

6 February 2024

 

Biome Technologies plc

("Biome", the "Company" or the "Group")

 

Trading Update

 

Biome Technologies plc, a leading bioplastics and radio frequency technology
business, today provides an unaudited pre-close Trading Update for the
financial year ended 31 December 2023.

 

Group revenues for the year ended 31 December 2023 were in line with current
market expectations at £7.0m and 13% ahead of the previous year (2022:
£6.2m).

 

The Group had a cash balance at the year-end of £0.6m (31 December 2022:
£0.8m) and had 2026 convertible loan notes outstanding of £0.85m and no bank
debt.

 

The Group's results for the year ended 31 December 2023 are scheduled to be
published on 29 April 2024.

 

Bioplastics Division

 

The division's revenues for the year to 31 December 2023 were £6.0m, an
increase of 36% on the prior year (2022: £4.4m).

 

The significant increase in revenues for the Bioplastics division was driven
by existing customers initiating larger orders and a broadening of the
customer and application base in North America.

 

Particular success has been achieved with the deployment of bioplastic polymer
grades that are suitable for making filmic materials that can be certified as
"Home Compostable". The market for home compostable materials appears to be
growing strongly and is a trend considered likely to continue. Significant
development focus is being deployed by Biome to extend the division's range of
home compostable materials to the market and it was pleasing to receive the
grant of a European Patent early in 2024 that underpins this new technology.

 

To continue to drive this growth in North America, we have further
strengthened our customer facing team in Canada to build on Biome's growing
brand presence and customer awareness.

 

Stanelco RF Technologies Division

 

Revenues in the RF Technologies division in 2023 were £0.9m (2022: £1.8m).
The reduction in sales reflects the timing of receipt of contracts and revenue
recognition in line with IFRS 15.

 

In the November 2023 Trading Update, we stated that the division was in
extended discussions with several potential customers regarding contracts that
would have revenue and profit recognition potential of significance for 2024.
The negotiations regarding these contracts have advanced significantly in
recent weeks and we are confident of bringing them to conclusion in the
relatively short-term.

 

Group Outlook

 

The Board is pleased with the strong progress of the Bioplastics division
throughout 2023 which continues to grow strongly in the face of some global
headwinds, evidencing the division's resilience. It is encouraging to see the
ongoing diversification of the customer base that will provide a broader
platform for further growth in due course, in line with our stated strategy.

 

Whilst there have been timing delays in progressing some of the RF division's
projects of scale, negotiations in relation to two of these are now
progressing well and the Board remains confident that these should
successfully complete in the relatively short-term.

 

The Group expects the current financial year to build on the trading momentum
being established in both divisions.

 

-Ends-

 For further information please contact:
 Biome Technologies plc

 Paul Mines, Chief Executive Officer
 Rob Smith, Chief Financial Officer
 www.biometechnologiesplc.com  Tel: +44 (0) 2380 867 100

 Allenby Capital
 David Hart/Alex Brearley (Nominated Adviser)

 Kelly Gardiner/Tony Quirke (Sales and Corporate Broking)
 www.allenbycapital.com        Tel: +44 (0) 20 3328 5656

 

About Biome

Biome Technologies plc is an AIM listed, growth-orientated, commercially
driven technology group. Our strategy is founded on building market-leading
positions based on patented technology and serving international customers in
valuable market sectors. We have chosen to do this by developing products in
application areas where the value-added pricing can be justified and are not
reliant on government legislation. These products are driven by customer
requirements and are compatible with existing manufacturing processes. They
are market rather than technology-led.

 

The Group comprises two divisions, Biome Bioplastics and RF Technologies.

 

Biome Bioplastics is a leading developer of highly-functional, bio-based and
biodegradable plastics. The division's mission is to produce bioplastics that
challenge the dominance of oil- based polymers.

 

RF Technologies designs, builds and services advanced radio frequency (RF)
systems. Dielectric and induction heating products are at the core of a
product offering that ranges from portable sealing devices to large furnaces
for the fibre optics markets.

 

www.biometechnologiesplc.com (http://www.biometechnologiesplc.com)
www.biomebioplastics.com (http://www.biomebioplastics.com) and
www.thinkbioplastic.com (http://www.thinkbioplastic.com)
www.stanelcorftechnologies.com (http://www.stanelcorftechnologies.com)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTQKPBNOBKDNBK